Literature DB >> 26795411

Intravitreal aflibercept for choroidal neovascularisation in angioid streaks.

S Vaz-Pereira1,2,3, L Collaço1, G De Salvo4, P van Zeller1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26795411      PMCID： PMC5108544          DOI： 10.1038/eye.2015.284

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Treat and extend regimen with aflibercept for choroidal neovascularization in angioid streaks.

Authors:  T Diago
Journal:  Eye (Lond)       Date:  2016-01-22       Impact factor: 3.775

Review 2.  Treatment of choroidal neovascularization due to angioid streaks: a comprehensive review.

Authors:  Martin Gliem; Robert P Finger; Rolf Fimmers; Christian K Brinkmann; Frank G Holz; Peter Charbel Issa
Journal:  Retina       Date:  2013 Jul-Aug       Impact factor: 4.256

3.  Intravitreal aflibercept for choroidal neovascularisation in angioid streaks.

Authors:  S Vaz-Pereira; L Collaço; G De Salvo; P van Zeller
Journal:  Eye (Lond)       Date:  2015-05-29       Impact factor: 3.775

4.  INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up.

Authors:  Julien Tilleul; Gerard Mimoun; Giuseppe Querques; Nathalie Puche; Jennyfer Zerbib; Franck Lalloum; Mayer Srour; Eric H Souied
Journal:  Retina       Date:  2016-03       Impact factor: 4.256

5.  Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials.

Authors:  Juan E Grunwald; Ebenezer Daniel; Jiayan Huang; Gui-Shuang Ying; Maureen G Maguire; Cynthia A Toth; Glenn J Jaffe; Stuart L Fine; Barbara Blodi; Michael L Klein; Alison A Martin; Stephanie A Hagstrom; Daniel F Martin
Journal:  Ophthalmology       Date:  2013-09-29       Impact factor: 12.079
  5 in total
  1 in total

1.  Intravitreal aflibercept for choroidal neovascularisation in angioid streaks.

Authors:  S Vaz-Pereira; L Collaço; G De Salvo; P van Zeller
Journal:  Eye (Lond)       Date:  2016-03-04       Impact factor: 3.775
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.